Wenyi Qin
ORCID: 0000-0001-5460-0325
· 1 paper in corpus
article
2011
BACKGROUND: In preclinical studies, müllerian inhibiting substance (MIS) has a protective affect against breast cancer. Our objective was to determine whether serum MIS concentrations were associated with cancerous or precancerous lesions. …